Novel apoptosis inducing agents in cancer therapy.
Mita
Monica
M
Institute for Drug Development, Cancer Therapy and Research Center, University of Texas Health Science Center, San Antonio, USA.
Tolcher
Anthony W
AW
D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D017209:Apoptosis / Q000187:drug effects*; D020169:Caspases / Q000187:drug effects / Q000378:metabolism; D049109:Cell Proliferation / Q000187:drug effects; D016503:Drug Delivery Systems; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000187:drug effects; D013873:Thionucleotides / Q000494:pharmacology* / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000187:drug effects / Q000378:metabolism
D000970:Antineoplastic Agents; D019253:Proto-Oncogene Proteins c-bcl-2; D013873:Thionucleotides; D014409:Tumor Necrosis Factor-alpha; C408162:oblimersen; D066246:ErbB Receptors; D020169:Caspases